Expression of gremlin, a gene involved in nephrogenesis, may not end after embryonic development and can reemerge in the context of diabetic nephropathy. Dr. Vincent Dolan, of University College Dublin, and colleagues evaluated gremlin expression in normal human adult kidneys and in kidneys with diabetic nephropathy.
Gremlin expression was not seen in the normal kidneys, whereas abundant expression was observed in the nephropathic kidneys, the investigators note. Further analysis revealed that gremlin expression was primarily confined to areas of tubulointerstitial fibrosis, typically in association with the expression of transforming growth factor-beta.
Although gremlin mRNA levels did not correlate with the degree of proteinuria, they were directly linked with the level of renal dysfunction, the authors note. Moreover, gremlin expression was strongly associated with the tubulointerstitial fibrosis score.
"Considered with reports from other investigators highlighting the prominence of gremlin expression in fibroblast cultures, these data suggest a role for gremlin in the pathogenesis of tubulointerstitial fibrosis," the researchers state. As such, gremlin could serve as a target for therapeutic intervention, they add.
Am J Kidney Dis 2005;45:1034-1039.
================================
Advertisement
At Advantage/OMC it is our mission to make your job easier by providing your patients with services and products of the highest quality.
We are a full service mail order pharmacy that can offer your patients a full line of prescription medications, blood glucose monitors and supplies, insulin pumps and supplies, as well as impotence devices. The Advantage/OMC alliance provides Major Medical Insurances through Advantage while OMC deals with Medicare Insurance.
https://www.diabetesincontrol.com/ads/omc/dest.php
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.